Santa Cruz Biotechnology offers a broad range of LRRC58 monoclonal antibodies for research applications. LRRC58 monoclonal antibodies are compatible with multiple experimental techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). LRRC58, or Leucine-Rich Repeat Containing 58, participates in cellular processes, including signal transduction and protein-protein interactions. Understanding LRRC58 function contributes to insights about disease mechanisms and potential therapeutic targets. Research involving LRRC58 advances knowledge in fields such as cancer research and neurobiology. LRRC58 monoclonal antibodies enable precise detection and characterization of cellular pathways and molecular interactions. Secondary antibody conjugates, including horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC), enhance visualization capabilities. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of cellular and molecular processes.